An important risk factor for nosocomial infection in an intensive care unit (ICU) is prior colonization. This study was undertaken to determine the spectrum of bacterial colonization and predisposing risk factors in patients being admitted to an ICU in India, with special emphasis on extended-spectrum b-lactamase (ESBL)-and metallo-b-lactamase (MBL)-producing Gramnegative bacteria. Nasal, oral and rectal swab samples were collected and processed for isolation of ESBL-producing Gram-negative bacteria and MBL-producing Pseudomonas aeruginosa and Acinetobacter species. Bacterial colonization (of one or more sites) on admission was detected in 51 out of 96 patients included in the study. Non-fermenters, i.e. P. aeruginosa and Acinetobacter baumannii, were the most common colonizers, present in 37 patients, with simultaneous colonization in 12 patients. A total of 16 patients were colonized with MBL-producing members of the family Enterobacteriaceae, out of which 11 isolates (from 5 patients) were also carrying ESBL-encoding genes. As for MBLs, most of our patients have shown colonization with ESBL-producing bacteria. On admission, 47 of 51 patients (92 %) have been colonized by ESBL-producing members of the family Enterobacteriaceae, at one or more of the three anatomical sites. The most common MBL subtype was bla IMP (51.56 %), whereas bla CTX was the most common gene (84.9 %) identified among ESBL producers. Risk factors for colonization on admission to the ICU were hospitalization for more than 48 h, use of ¢3 groups of antibiotics, co-morbidities and mechanical ventilation for more than 48 h prior to ICU admission. There is an increasing incidence of MBLs and ESBLs in the Indian population. The identified risk factors can be used as a guide for empiric antibiotic therapy targeted to these resistant bacteria.
INTRODUCTION
The incidence of nosocomial infections in critically ill patients is much higher than in general ward patients despite the immense advancement in therapeutic technologies (Bryan-Brown, 1992; Brawley et al., 1989) . Severe nosocomial infections contribute to prolonged intensive care unit (ICU) stays, increased morbidity and mortality, and of course increased resource utilization (Heyland et al., 1999; Inan et al., 2005) . An important risk factor for nosocomial infection is prior colonization . The Indian literature lacks evidence about the incidence and patterns of colonization of multidrug-resistant bacteria [especially the metallo-blactamase (MBL)-or extended-spectrum b-lactamase (ESBL)-producing bacteria] amongst critically ill patients.
This study was undertaken to determine the spectrum of bacterial colonization in patients admitted to an ICU and to assess the predisposing risk factors for colonization. Emphasis was laid on ESBL-and MBL-producing Gramnegative bacteria.
METHODS
Settings. The study was conducted in a 700 bed tertiary care hospital, in North India, with a 12 bed ICU that receives patients from within the hospital as well as ones referred from outside. It manages approximately 250-300 critically ill patients annually.
Study population. After ethical clearance by the institute (Sanjay Gandhi Postgraduate Institute of Medical Sciences) and after taking informed consent from the next of kin, all patients admitted between March 2008 and July 2009 were prospectively included in the study. Patients were excluded if they were neutropenic, had pneumonia on admission or had received previous selective digestive decontamination.
Collection of data. Demographic data, clinical characteristics and details of previous hospitalizations were analysed. Nasal, oral and rectal swab samples were collected at the ICU upon admission.
Microbiological studies. All the swabs were processed for isolation of ESBL-producing Gram-negative bacteria and other Gram-negative bacilli, in addition to MBL-producing Pseudomonas aeruginosa and Acinetobacter species. Gram-negative bacteria were isolated on Chrome agar (supplied by Himedia). Isolates were identified to the species level by standard biochemical tests. The antibiotic susceptibility pattern for the following antibiotics were obtained by the Kirby-Bauer disc diffusion method on Muller-Hinton agar (Himedia) according to Clinical and Laboratory Standards Institute guidelines (CLSI, 2006) : amoxicillin, ceftazidime, ceftriaxone, cefotaxime, aztreonam, cefpodoxime, ciprofloxacin, cefoxitin, levofloxacin, gentamicin, amikacin, imipenem, meropenem.
The Gram-negative isolates (including members of the family Enterobacteriaceae, Pseudomonas spp. and Acinetobacter spp.) that were non-susceptible to imipenem (10 mg disc) and/or meropenem (10 mg disc) were tested phenotypically for MBL production using a modified Hodge and imipenem-EDTA combined disc test (Lee et al., 2001; Franklin et al., 2006) while the members of the family Enterobacteriaceae showing resistance (or decreased zone diameter according to the ESBL screening method of the Clinical and Laboratory Standards Institute) to third generation cephalosporins (i.e. ceftazidime, ceftriaxone, cefotaxime, aztreonam, cefpodoxime) were tested for ESBL production using disc potentiation and disc approximation methods (NCCLS, 2000; Jarlier et al., 1988) .
Further, genotypic confirmation was carried out for the presence of these enzymes. All infections were divided into specific infection sites using standard criteria established by the Centers for Disease Control and Prevention (Garner et al., 1988) .
Genotyping
Genotypic detection of MBL genes. A multiplex PCR assay was performed to detect and differentiate five families of acquired MBLencoding genes (VIM, IMP, SPM, GIM and SIM families) in a single reaction. Conserved regions of all available bla IMP , bla VIM , bla SPM-1 , bla GIM-1 , bla SM-1 alleles were identified in CLUSTAL multiple alignments (Ellington et al., 2007) . Five primer pairs, specific for each family of acquired MBLs, were designed to amplify products of 188 bp (IMP), 390 bp (VIM), 271 bp (SPM-1), 477 bp (GIM-1), 570 bp (SIM-1) (Ellington et al., 2007) (Table 1) .
DNA template was prepared by emulsifying five colonies in 100 ml PCR-grade water and adding 2 ml to the PCR mixture prior to thermal cycling. The cycling conditions were: initial DNA release and denaturation at 94 uC for 5 min; followed by 40 cycles of 94 uC for 30 s, 52 uC for 40 s and 72 uC for 50 s; followed by a single, final, elongation step at 72 uC for 5 min. The amplified PCR product was analysed on 2 % agarose containing 1 ml (0.5 mg ml 21 ) ethidium bromide ml
21
. The amplified product was examined for the presence of multiple bands under UV transillumination (UVS system).
Genotypic detection (PCR) of ESBL-encoding genes. A PCR assay was performed to detect and differentiate bla TEM , bla SHV and bla CTX-M genes. DNA template was prepared by extracting plasmid DNA by the alkali lysis method (Sambrook et al., 1989) . Extracted DNA of all the phenotypically confirmed ESBL-producing strains was subjected to amplification by PCR using bla TEM -/bla SHV -/bla CTX-M -specific primers. The primers to amplify the targeted genes were chosen from earlier published studies and were able to recognize all the known TEM, SHV and CTX-M variants (Edelstein et al., 2003; Lee et al., 2000) .
The primers were procured from OPERON Biotechnologies. A final reaction volume of 25 ml was prepared with H 2 O (Milli-Q grade), 20 pmol both primers, 1 mM each dNTP, 1 unit Taq polymerase, 2.5 ml 106PCR buffer, 1.5 mM MgCl 2 , 100 ng DNA template. Amplification reactions were carried out in a thermocycler (PTC-100; MJ Research) under the following conditions: initial denaturation at 96 uC for 3 min, followed by 35 cycles of denaturation at 96 uC for 30 s, annealing as specified and elongation at 72 uC for 30 s. The final elongation step was extended to 3 min at 72 uC.
Statistical analysis. All the statistical calculations were performed using Epi Info (version 3.5.1) statistical software. Statistical analyses of individual risk factors were done by Fischer's exact test and x 2 test. Yates correction was applied where required. A P value ,0.05 was considered significant. 
RESULTS

Demographic data of patients
A total of 96 patients, 78 male and 18 female (age 19-76 years, mean±SD 54.3±14) met the inclusion criteria. Two-thirds of the patients had been admitted to hospital ¢48 h prior to ICU admission, and 80 of 96 (83 %) had been treated with ¢3 groups of antibiotics. Among pretreated patients, 23 of 96 (24 %) were surgical patients and received a perioperative infection prophylaxis, the rest of the patients were medical patients of which the majority had received .3 groups of antibiotics. The demographic characteristics of all patients are summarized in Table 2 .
Bacterial pattern of colonization on admission
All 3 sites of the 96 patients were sampled to assess colonization. Bacterial colonization (of 1 or more sites) on admission was detected in 51 patients. Non-fermenters, i.e. P. aeruginosa and Acinetobacter baumannii, were the most common colonizers, present in 37 patients, with simultaneous colonization in 12 patients. Sixteen patients were colonized with MBL-producing members of the family Enterobacteriaceae, out of which 11 isolates (from 5 patients) were also carrying ESBL-encoding genes. The spectrum of bacterial colonization on admission is given in Table 3 .
Risk factors for colonization
Risk factors for colonization identified at ICU admission were mechanical ventilation ¢48 h before admission (P¡0.0001), use of ¢3 groups of antibiotic (P¡0.0009), co-morbidities (P¡0.0013) and a hospital stay for ¢48 h prior to ICU admission (P¡0.0021). Factors not associated with risk of colonization were sex, age, smoking and alcohol abuse (Table 4) .
Genotypic detection of MBL-encoding genes in the isolates
The most common MBL subtype was bla IMP (51.56 %) in all the isolates except Klebsiella pneumoniae in which bla VIM was the most common subtype (Tables 5 and 6 ).
Genotypic detection of ESBL-encoding genes in the isolates
On admission, 47 out of 51 patients (92 %) had been colonized by ESBL-producing members of the family Enterobacteriaceae, at one or more of the three anatomical sites. In our isolates, bla CTX was the most common gene (83.3 %) identified among ESBL producers (Table 7) .
DISCUSSION
The socioeconomic impact of this colonization leading to nosocomial infections can adversely affect the patients', as well as the nation's, economic burden (Jarvis, 1996) . In this study, we have analysed the incidence and pattern of bacterial colonization including multidrug-resistant Gramnegative bacteria in patients at ICU admission.
The majority of our patients showed colonization with MBL-producing bacteria. On admission, amongst the 51 colonized patients, 37 patients (73 %) had been colonized by MBL-producing P. aeruginosa or Acinetobacter species, at one or more of the three anatomical sites. (24) COPD, Chronic obstructive pulmonary disease. Amongst ESBL producers, bla CTX was the most common gene (83.3 %) identified. To the best of our knowledge, this may be the one of the few studies from India where a high prevalence of the bla CTX gene in ESBL strains from critically ill patients is being detected (Muzaheed et al., 2008; Ensor et al., 2006) . Another interesting finding is that from different colonization sites we have isolated several strains of P. aeruginosa, A. baumannii and Enterobacteriaceae having multiple MBL-encoding genes.
The reason for the high prevalence of bla CTX may be the clonal spread of the plasmid containing the bla CTX-M gene amongst the various members of the family Enterobacteriaceae in different hospitals including ours (Sanjay Gandhi Postgraduate Institute of Medical Sciences). Our findings support the hypothesis that CTX-M enzymes are the dominant ESBLs worldwide. Pournaras et al. (2004) reported an 87 % prevalence of CTX-M enzyme amongst ESBL producers. In a multicentre study from Russia, Edelstein et al. (2003) observed positive amplification for the bla CTX-M gene in 28 (35.9 %) Escherichia coli and 87 (34.9 %) K. pneumoniae isolates expressing the ESBL phenotype. CTX-M b-lactamases were detected in 21 (75 %) surveyed hospitals from the cities representing geographically distant areas of Russia, and in five (17.9 %) hospitals this was the predominant ESBL. Brenwald et al. (2003) reported an outbreak of CTX-M harbouring ESBL in the UK. In a nationwide survey in Italy, Luzzaro et al. (2006) found CTX-M-producing isolates in 10 of the 11 participating centres distributed across the Italian national territory, although at remarkably variable rates in different centres (1.2 to 49.5 % of the ESBL producers). In our study, a total of 83 (56.8 %) isolates contained multiple b-lactamase genes; the bla CTX-M gene was associated with TEM in 64 isolates and with SHV in 27 isolates. Thirteen isolates showed all the three ESBL types.
Major risk factors associated with colonization at admission were prior hospitalization for .48 h, use of ¢ 3 groups of antibiotics, associated co-morbidities and mechanical ventilation for ¢48 h prior to ICU admission, which corroborates the findings of some other related studies (Drakulovic et al., 2001; Harris et al., 2007) . The limitation of this study is that we could not study any specific antibiotic groups as we didn't have complete patient information on admission, maybe because of the poor referral system still prevailing in our country.
There is an increasing trend of MBLs and ESBLs in the Indian population. Approximately 50 % of our patients were colonized by MBL-and ESBL-producing P. aeruginosa, Acinetobacter species or Enterobacteriaceae, at one or more of three anatomical sites. The risk factors identified in our study are potentially important because they can help determine which patients may need empiric antimicrobial drug therapy targeted to the ESBL-producing and MBL-producing bacteria. In addition, the colonization pattern and the risk factors identified may be of use to hospital antimicrobial drug stewardship and public health programmes. 
